273
Participants
Start Date
September 30, 2003
Primary Completion Date
August 31, 2007
Study Completion Date
September 30, 2010
5-Fluorouracil
"FEC Chemotherapy: 500 mg/m\^2 IV on day 1 of 21 day cycle.~FAC Chemotherapy: 500 mg/m\^2 IV on day 1 and day 4 of 21 day cycle."
Cyclophosphamide
"FAC and FEC Chemotherapy:~500 mg/m\^2 IV on day 1 of 21 day cycle."
Doxorubicin
FAC Chemotherapy: 50 mg/m\^2 IV on day 1 over 72 hour continuous infusion or IV bolus.
Paclitaxel
80 mg/m\^2 by vein (IVPB) over 1 hour every week for 12 weeks
Epirubicin
FEC: 100 mg/m\^2 IV on day 1 of 21 day cycle.
UT MD Anderson Cancer Center, Houston
Centro Medico Nacional de Occidente, Guadalajara
Instituto Nacional de Enfermedades Neoplasicas, Lima
Grupo Español de Investigacion en Cancer de Mama, Madrid
Collaborators (1)
Breast Cancer Research Foundation
OTHER
M.D. Anderson Cancer Center
OTHER